C4 Therapeutics (CCCC) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for C4 Therapeutics (CCCC) over the last 6 years, with Q3 2025 value amounting to 0.02.
- C4 Therapeutics' Asset Utilization Ratio rose 499.93% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year increase of 499.93%. This contributed to the annual value of 0.1 for FY2024, which is 9062.19% up from last year.
- As of Q3 2025, C4 Therapeutics' Asset Utilization Ratio stood at 0.02, which was up 499.93% from 0.02 recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Asset Utilization Ratio ranged from a high of 0.04 in Q1 2021 and a low of 0.01 during Q2 2023
- For the 5-year period, C4 Therapeutics' Asset Utilization Ratio averaged around 0.02, with its median value being 0.02 (2022).
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 8571.99% in 2021, then surged by 11238.49% in 2024.
- C4 Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.02 in 2021, then tumbled by 34.69% to 0.02 in 2022, then fell by 14.19% to 0.01 in 2023, then skyrocketed by 70.21% to 0.02 in 2024, then decreased by 0.12% to 0.02 in 2025.
- Its last three reported values are 0.02 in Q3 2025, 0.02 for Q2 2025, and 0.03 during Q1 2025.